Random triples
| Subject | Object |
|---|---|
| gptkb:Tafasitamab | BLA |
| gptkb:Selinexor | New Drug Application (NDA) |
| gptkb:ipilimumab | Biologics License Application |
| gptkb:dapagliflozin | new drug application |
| gptkb:saxagliptin | new drug application |
| gptkb:Aduhelm | accelerated approval |
| gptkb:Gleevec | New Drug Application |